This topic contains a solution. Click here to go to the answer

Author Question: Which of the following interfaces is/are most commonly used to apply noninvasive ventilation (NIV) ... (Read 77 times)

Capo

  • Hero Member
  • *****
  • Posts: 545
Which of the following interfaces is/are most commonly used to apply noninvasive ventilation (NIV) in the acute setting? 1. Nasal or full-face mask 2. Mouthpiece 3. Endotracheal tube 4. Nasal pillows
 
  a. 1 and 2 only
  b. 1 and 3 only
  c. 1, 2, and 4 only
  d. 1 only

Question 2

Your patient is being ventilated with a nasal mask to relieve dyspnea. He has a long history of chronic obstructive pulmonary disease and hypercarbia. What is the goal of noninvasive ventila-tion in this setting with regard to the ABGs?
 
  a. Return the PaCO2 to 40 to 45 mm Hg.
  b. Return the pH to near normal.
  c. Return the PaCO2 to less than 60 mm Hg.
  d. Return the bicarbonate level to near nor-mal.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mochi09

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

ANS: A
Full-face and nasal masks are the most commonly used interfaces in the acute care setting.

Answer to Question 2

ANS: C





 

Did you know?

The average older adult in the United States takes five prescription drugs per day. Half of these drugs contain a sedative. Alcohol should therefore be avoided by most senior citizens because of the dangerous interactions between alcohol and sedatives.

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

Chronic marijuana use can damage the white blood cells and reduce the immune system's ability to respond to disease by as much as 40%. Without a strong immune system, the body is vulnerable to all kinds of degenerative and infectious diseases.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library